NASDAQ
Mosaic ImmunoEngineering Inc. (CPMV) has a price/fcf ratio of -20.20x as of Monday, May 25, 2026. This represents a 96.71% decrease compared to its 12-month average of -10.27x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.